Vericel Corp. (VCEL)
58.52
+0.26
(+0.45%)
USD |
NASDAQ |
Nov 20, 11:00
Vericel Free Cash Flow : 57.89M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 57.89M |
| June 30, 2026 | 61.66M |
| March 31, 2026 | 47.49M |
| December 31, 2025 | 24.75M |
| September 30, 2025 | 20.38M |
| June 30, 2025 | -8.301M |
| March 31, 2025 | -6.608M |
| December 31, 2024 | -5.811M |
| September 30, 2024 | -12.02M |
| June 30, 2024 | -2.19M |
| March 31, 2024 | 2.036M |
| December 31, 2023 | 7.798M |
| September 30, 2023 | 11.40M |
| June 30, 2023 | 12.41M |
| March 31, 2023 | 7.575M |
| December 31, 2022 | 9.015M |
| September 30, 2022 | 12.72M |
| June 30, 2022 | 12.28M |
| March 31, 2022 | 13.77M |
| December 31, 2021 | 21.12M |
| September 30, 2021 | 21.83M |
| June 30, 2021 | 24.86M |
| March 31, 2021 | 18.72M |
| December 31, 2020 | 14.95M |
| September 30, 2020 | 7.468M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.13M |
| March 31, 2020 | -5.752M |
| December 31, 2019 | -9.799M |
| September 30, 2019 | -10.55M |
| June 30, 2019 | -16.52M |
| March 31, 2019 | -3.389M |
| December 31, 2018 | -3.09M |
| September 30, 2018 | -5.008M |
| June 30, 2018 | -11.66M |
| March 31, 2018 | -11.28M |
| December 31, 2017 | -14.69M |
| September 30, 2017 | -24.22M |
| June 30, 2017 | -22.88M |
| March 31, 2017 | -23.22M |
| December 31, 2016 | -21.31M |
| September 30, 2016 | -16.03M |
| June 30, 2016 | -13.10M |
| March 31, 2016 | -12.59M |
| December 31, 2015 | -15.77M |
| September 30, 2015 | -18.63M |
| June 30, 2015 | -25.63M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | -26.24M |
| September 30, 2014 | -23.59M |
| June 30, 2014 | -19.24M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 81.99M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
| Anika Therapeutics, Inc. | 2.295M |
| Savara, Inc. | -130.94M |
| Arrowhead Pharmaceuticals, Inc. | -283.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 17.72M |
| Cash from Investing (Quarterly) | -2.708M |
| Cash from Financing (Quarterly) | -6.88M |
| Free Cash Flow Per Share (Quarterly) | 0.2961 |
| Free Cash Flow to Equity (Quarterly) | 17.66M |
| Free Cash Flow to Firm (Quarterly) | 15.84M |
| Free Cash Flow Yield | 1.94% |